BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6864764)

  • 1. Characterization of the circulating immune complexes in acute and chronic liver diseases.
    Schena FP; Pastore G; Pastore A; Angarano G; Meliconi L; Schiraldi O; Bonomo L
    J Clin Lab Immunol; 1983 Apr; 10(4):179-83. PubMed ID: 6864764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K; Nagashima H; Tsuji T
    Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes in acute viral hepatitis, chronic active hepatitis, and periarteritis nodosa (author's transl)].
    Hütteroth TH; Arnold W; Hopf U; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1978 Jun; 16(6):395-402. PubMed ID: 27909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN; Vieira LM; Alvariz FG
    Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes in patients with acute and chronic diseases of the liver].
    Uibo RM; Nutt HR; Prjukk TJ
    Ter Arkh; 1989; 61(2):61-4. PubMed ID: 2524905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal immune complexes in viral hepatitis.
    Sehgal S; Datta BN; Chugh KS; Aikat BK; Datta DV
    Clin Exp Immunol; 1980 Jun; 40(3):453-8. PubMed ID: 6998616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
    Biglino A; Cariti G; Gioannini P
    Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complex levels and HBs-antigenaemia in healthy Nigerians and patients with liver diseases.
    Okerengwo AA; Atoba MA
    Afr J Med Med Sci; 1992 Dec; 21(2):35-8. PubMed ID: 1308079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance.
    Rizzi R; Almi P; Touscoz G; Canese MG; Toti M; Palla M; Bonino F
    Boll Ist Sieroter Milan; 1983 May; 62(2):137-44. PubMed ID: 6626320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen.
    Brown SE; Howard CR; Steward MW; Viola L; Murray-Lyon IM
    Dev Biol Stand; 1983; 54():391-7. PubMed ID: 6653894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes.
    Caredda F; De Franchis R; D'Arminio Monforte A; Vecchi M; Antoniozzi F; Rossi E; Primignani M; Moroni M
    Boll Ist Sieroter Milan; 1984; 63(6):496-8. PubMed ID: 6534395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence and dynamics of circulating immune complexes in acute viral hepatitis HBsAg positive and negative (author's transl)].
    Pintera J; Jezek P; Horecká J; Krajcová M
    Cas Lek Cesk; 1981 Apr; 120(17):513-7. PubMed ID: 7237498
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
    Araki K; Tsuji T; Onoue K; Tsuchiya M; Shinohara T; Inoue J; Nagashima H
    Acta Med Okayama; 1980 Mar; 34(2):131-8. PubMed ID: 6450515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgM/HBsAG complexes in hepatitis B virus infections].
    Almi P; Fanetti G; Toti M; Rubino M
    Quad Sclavo Diagn; 1982 Sep; 18(3):340-4. PubMed ID: 7184047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of HBsAg determinants in immune complexes from hepatitis B virus-associated vasculitis.
    Gupta RC; Kohler PF
    J Immunol; 1984 Mar; 132(3):1223-8. PubMed ID: 6198385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.